Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The MAP kinase pathway is required for entry into mitosis and cell survival

Abstract

In this communication, we examined the role of the MAP kinase pathway in the G2/M phase of the cell cycle. Activation of the Plk1 and MAP kinase pathways was initially evaluated in FT210 cells, which arrest at G2 phase at the restrictive temperature (39°C), due to a mutation in the cdc2 gene. Previous studies had shown that these cells enter mitosis at the nonpermissive temperature upon incubation with okadaic acid, a protein phosphatase 1 and 2A inhibitor. We show that treatment of FT210 cells at 39°C with okadaic acid activated Plk1, as shown by hyperphosphorylation and elevated protein kinase activity, and also induced activation of the MAP kinase pathway. The specific Mek inhibitor PD98059 antagonized the okadaic acid-induced activation of both Plk1 and MAP kinases. This suggests that activation of the MAP kinase pathway may contribute to the okadaic acid-induced activation of Plk1 in FT210 cells at 39°C. We also found that PD98059 strongly attenuated progression of HeLa cells through mitosis, and active Mek colocalizes with Plk1 at mitotic structures. To study the potential function of the MAP kinase pathway during mitosis, RNAi was used to specifically deplete five members of this pathway (Raf1, Mek1/2, Erk1/2). Each of these five protein kinases is required for cell proliferation and survival, and depletion of any of these proteins eventually leads to apoptosis. Treatment with Mek inhibitors also inhibited cell proliferation and caused apoptosis. A dramatic increase of Plk1 activities and a moderate increase of Cdc2 activities in Raf1-depleted cells indicate that Raf1-depleted cells arrest in the late G2 or M phase. Mek1 and Erk1 depletion also caused cell cycle arrest at G2, suggesting that these enzymes are required for the G2/M transition, whereas the loss of Mek2 or Erk2 caused arrest at G1.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 11
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

Abbreviations

Plk1:

polo-like kinase 1

TCTP:

translationally controlled tumor protein

MBP:

mylein basic protein

IP:

immunoprecipitation

GST:

glutathione S-transferase

RNAi:

RNA interference

MAPK:

mitogen-activated protein kinase

Mek:

mitogen-activated protein kinase/extracellular signal-regulated kinase kinase

Erk:

extracellular signal-regulated kinase

References

  • Abrieu A, Brassac T, Galas S, Fisher D, Labbe JC and Doree M . (1998). J. Cell Sci., 111, 1751–1757.

  • Ajiro K, Yoda K, Utsumi K and Nishikawa Y . (1996). J. Biol. Chem., 271, 13197–13201.

  • Alessi DR, Cuenda A, Cohen P, Dudley DT and Saltiel AR . (1995). J. Biol. Chem., 270, 27489–27494.

  • Belanger L, Roy S, Tremblay M, Brott B, Steff A, Mourad W, Hugo P, Erikson R and Charron J . (2003). Mol. Cell. Biol., 23, 4778–4787.

  • Cowley S, Paterson H, Kemp P and Marshall CJ . (1994). Cell, 77, 841–852.

  • Descombes P and Nigg EA . (1998). EMBO J., 17, 1328–1335.

  • Giroux S, Tremblay M, Bernard D, Cardin-Girard JF, Aubry S, Larouche L, Rousseau S, Huot J, Landry J, Jeannotte L and Charron J . (1999). Curr. Biol., 9, 369–372.

  • Gowdy PM, Anderson HJ and Roberge M . (1998). J. Cell Sci., 111, 3401–3410.

  • Guadagno TM and Ferrell JE . (1998). Science, 282, 1312–1315.

  • Guo XW, Th'ng JP, Swank RA, Anderson HJ, Tudan C, Bradbury EM and Roberge M . (1995). EMBO J., 14, 976–985.

  • Haccard O, Lewellyn A, Hartley RS, Erikson E and Maller JL . (1995). Dev. Biol., 168, 677–682.

  • Hamanaka R, Smith MR, O'Connor PM, Maloid S, Mihalic K, Spivak JL, Longo DL and Ferris DK . (1995). J. Biol. Chem., 270, 21086–21091.

  • Harding A, Giles N, Burgess A, Hancock JF and Gabrielli BG . (2003). J. Biol. Chem., 278, 16747–16754.

  • Hayne C, Tzivion G and Luo Z . (2000). J. Biol. Chem., 275, 31876–31882.

  • Huang W and Erikson RL . (1994). Proc. Natl. Acad. Sci. USA, 91, 8960–8963.

  • Kapoor TM, Mayer TU, Coughlin ML and Mitchison TJ . (2000). J. Cell Biol., 150, 975–988.

  • Kolch W . (2000). Biochem. J., 351, 289–305.

  • Kotani S, Tugendreich S, Fujii M, Jorgensen PM, Watanabe N, Hoog C, Hieter P and Todokoro K . (1998). Mol. Cell, 1, 371–380.

  • Kumagai A and Dunphy WG . (1991). Cell, 64, 903–914.

  • Kumagai A and Dunphy WG . (1996). Science, 273, 1377–1380.

  • Lane HA and Nigg EA . (1996). J. Cell Biol., 135, 1701–1713.

  • Lane HA and Nigg EA . (1997). Trends Cell Biol., 7, 63–68.

  • Lee KS and Erikson RL . (1997). Mol. Cell. Biol., 17, 3408–3417.

  • Lee KS, Yuan YL, Kuriyama R and Erikson RL . (1995). Mol. Cell. Biol., 15, 7143–7151.

  • Lees E . (1995). Curr. Opin. Cell Biol., 7, 773–780.

  • Liu X and Erikson RL . (2002). Proc. Natl. Acad. Sci. USA, 99, 8672–8676.

  • Liu X and Erikson RL . (2003). Proc. Natl. Acad. Sci. USA, 100, 5789–5794.

  • Macdonald SG, Crews CM, Wu L, Driller J, Clark R, Erikson RL and McCormick F . (1993). Mol. Cell. Biol., 13, 6615–6620.

  • Miltenberger RJ, Cortner J and Farnham PJ . (1993). J. Biol. Chem., 268, 15674–15680.

  • Minshull J, Sun H, Tonks NK and Murray AW . (1994). Cell, 79, 475–486.

  • Nigg EA . (1993). Trends Cell Biol., 3, 296–301.

  • Ohkura H, Hagan IM and Glover DM . (1995). Genes Dev., 9, 1059–1073.

  • Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S and Pouyssegur J . (1993). Proc. Natl. Acad. Sci. USA, 90, 8319–8323.

  • Qian YW, Erikson E and Maller JL . (1999). Mol. Cell. Biol., 19, 8625–8632.

  • Shapiro PS, Vaisberg E, Hunt AJ, Tolwinski NS, Whalen AM, McIntosh JR and Ahn NG . (1998). J. Cell Biol., 142, 1533–1545.

  • Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA and Medema RH . (2000). Nat. Cell Biol., 2, 672–676.

  • Sohaskey ML and Ferrell JE . (1999). Mol. Biol. Cell, 10, 3729–3743.

  • Sui G, Soohoo C, Affar EB, Gay F, Shi Y, Forrester WC and Shi Y . (2002). Proc. Natl. Acad. Sci. USA, 99, 5515–5520.

  • Takenaka K, Gotoh Y and Nishida E . (1997). J. Cell Biol., 136, 1091–1097.

  • Tamemoto H, Kadowaki T, Tobe K, Ueki K, Izumi T, Chatani Y, Kohno M, Kasuga M, Yazaki Y and Akanuma Y . (1992). J. Biol. Chem., 267, 20293–20297.

  • Th'ng JP, Wright PS, Hamaguchi J, Lee MG, Norbury CJ, Nurse P and Bradbury EM . (1990). Cell, 63, 313–324.

  • Treisman R . (1996). Curr. Opin. Cell Biol., 8, 205–215.

  • Walter SA, Cutler Jr RE, Martinez R, Gishizky M and Hill RJ . (2003). J. Biol. Chem., 278, 18221–18228.

  • Wojnowski L, Stancato LF, Larner AC, Rapp UR and Zimmer A . (2000). Mech. Dev., 91, 97–104.

  • Wojnowski L, Stancato LF, Zimmer AM, Hahn H, Beck TW, Larner AC, Rapp UR and Zimmer A . (1998). Mech. Dev., 76, 141–149.

  • Wright JH, Munar E, Jameson DR, Andreassen PR, Margolis RL, Seger R and Krebs EG . (1999). Proc. Natl. Acad. Sci. USA, 96, 11335–11340.

  • Yarm FR . (2002). Mol. Cell. Biol., 22, 6209–6221.

  • Zecevic M, Catling AD, Eblen ST, Renzi L, Hittle JC, Yen TJ, Gorbsky GJ and Weber MJ . (1998). J. Cell Biol., 142, 1547–1558.

Download references

Acknowledgements

We thank Eleanor Erikson for critical reading of this manuscript. This work was supported by the National Institutes of Health grant GM59172. RLE is the John F Drum American Cancer Society Professor of Cellular and Developmental Biology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaoqi Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, X., Yan, S., Zhou, T. et al. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23, 763–776 (2004). https://doi.org/10.1038/sj.onc.1207188

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207188

Keywords

This article is cited by

Search

Quick links